ROYAL BANK OF CANADA - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$9,000
-50.0%
1,615
-88.4%
0.00%
Q4 2018$18,000
-67.3%
13,927
-12.1%
0.00%
Q3 2018$55,000
+243.8%
15,853
+374.6%
0.00%
Q2 2018$16,000
+45.5%
3,340
+3.3%
0.00%
Q1 2018$11,000
-15.4%
3,233
+0.6%
0.00%
Q4 2017$13,000
-23.5%
3,215
+100.7%
0.00%
Q3 2017$17,000
+325.0%
1,602
+154.3%
0.00%
Q1 2017$4,000
-20.0%
630
-29.1%
0.00%
Q4 2016$5,000
+400.0%
888
+1133.3%
0.00%
Q3 2016$1,00072
+132.3%
0.00%
Q4 2015$0
-100.0%
31
-93.6%
0.00%
Q3 2015$6,000
-73.9%
482
-57.9%
0.00%
Q2 2015$23,0001,1460.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders